STOCK TITAN

Carilion Clinic further expands quality cardiac care access with latest Philips innovations at new regional cardiovascular institute in Virginia, US

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Carilion Clinic is expanding its cardiovascular care capabilities with Philips (NYSE: PHG) innovations at its new Cardiovascular Institute in Virginia. The facility will feature 11 specialized Philips interventional suites, enabling local treatment of complex cardiovascular conditions. Philips' integrated ecosystem includes the Azurion Image-Guided Therapy System, EPIQ CVx cardiology ultrasound with AI capabilities, and IntraSight with SyncVision for imaging and physiology.

This technology offers reduced X-ray dose, improved workflow, and more efficient turnaround times. The collaboration aims to set new standards in cardiovascular care, providing Carilion's staff with world-class technology and ongoing clinical education. This expansion reinforces Carilion's commitment to delivering high-quality, patient-centered care in the region.

Carilion Clinic sta espandendo le sue capacità di assistenza cardiovascolare con le innovazioni di Philips (NYSE: PHG) nel nuovo Istituto Cardiovascolare in Virginia. La struttura presenterà 11 sale di intervento specializzate Philips, che consentiranno il trattamento locale di condizioni cardiovascolari complesse. L'ecosistema integrato di Philips include il Sistema di Terapia Guidata da Immagini Azurion, l'ecografo cardiologico EPIQ CVx con capacità di intelligenza artificiale e IntraSight con SyncVision per immagini e fisiologia.

Questa tecnologia offre una riduzione della dose di raggi X, un flusso di lavoro migliorato e tempi di risposta più efficienti. La collaborazione mira a stabilire nuovi standard nella cura cardiovascolare, fornendo allo staff di Carilion tecnologie all'avanguardia e formazione clinica continua. Questa espansione rinforza l'impegno di Carilion a fornire cure di alta qualità e centrate sul paziente nella regione.

Carilion Clinic está ampliando sus capacidades de atención cardiovascular con las innovaciones de Philips (NYSE: PHG) en su nuevo Instituto Cardiovascular en Virginia. La instalación contará con 11 salas de intervención especializadas de Philips, permitiendo el tratamiento local de condiciones cardiovasculares complejas. El ecosistema integrado de Philips incluye el Sistema de Terapia Guiada por Imágenes Azurion, el ecógrafo cardiológico EPIQ CVx con capacidades de IA, y IntraSight con SyncVision para imágenes y fisiología.

Esta tecnología ofrece una dosis de rayos X reducida, un flujo de trabajo mejorado y tiempos de respuesta más eficientes. La colaboración tiene como objetivo establecer nuevos estándares en la atención cardiovascular, proporcionando al personal de Carilion tecnología de clase mundial y educación clínica continua. Esta expansión refuerza el compromiso de Carilion de ofrecer atención de alta calidad centrada en el paciente en la región.

Carilion Clinic는 버지니아에 있는 새로운 심혈관 연구소에서 Philips (NYSE: PHG)의 혁신으로 심혈관 치료 능력을 확장하고 있습니다. 이 시설은 11개의 전문 Philips 중재 수술실을 갖추고 있어 복잡한 심혈관 질환의 지방 치료를 가능하게 합니다. Philips의 통합 에코시스템에는 Azurion 영상 유도 치료 시스템, AI 기능을 갖춘 EPIQ CVx 심장 초음파, 그리고 이미징 및 생리학을 위한 IntraSight with SyncVision이 포함되어 있습니다.

이 기술은 X-선 노출 감소, 개선된 작업 흐름 및 더 효율적인 처리 시간을 제공합니다. 이 협력은 심혈관 치료의 새로운 기준을 설정하는 것을 목표로 하며, Carilion 직원에게 세계적 수준의 기술과 지속적인 임상 교육을 제공합니다. 이 확장은 Carilion이 지역에서 고품질의 환자 중심 치료를 제공하겠다는 의지를 강화합니다.

Carilion Clinic élargit ses capacités en matière de soins cardiovasculaires grâce aux innovations de Philips (NYSE: PHG) dans son nouvel Institut Cardiovasculaire en Virginie. L'établissement comprendra 11 salles d'intervention spécialisées Philips, permettant un traitement local des affections cardiovasculaires complexes. L'écosystème intégré de Philips comprend le Système de Thérapie Guidée par l'Image Azurion, l'ultrason cardiologique EPIQ CVx avec des capacités d'IA, et IntraSight avec SyncVision pour l'imagerie et la physiologie.

Cette technologie offre une dose de rayons X réduite, un flux de travail amélioré et des temps de traitement plus efficaces. La collaboration vise à établir de nouvelles normes en matière de soins cardiovasculaires, en fournissant au personnel de Carilion une technologie de classe mondiale et une formation clinique continue. Cette expansion renforce l'engagement de Carilion à offrir des soins de haute qualité centrés sur le patient dans la région.

Carilion Clinic erweitert ihre kardiovaskulären Versorgungsfähigkeiten mit den Innovationen von Philips (NYSE: PHG) in ihrem neuen Kardiovaskulären Institut in Virginia. Die Einrichtung wird 11 spezialisierte Philips Eingriffsräume umfassen, die eine lokale Behandlung komplexer kardiovaskulärer Erkrankungen ermöglichen. Das integrierte Ökosystem von Philips umfasst das Azurion Bildgeführte Therapiesystem, den EPIQ CVx Kardiologie Ultraschall mit KI-Funktionen und IntraSight mit SyncVision für Bildgebung und Physiologie.

Diese Technologie bietet eine reduzierte Röntgendosis, verbesserte Arbeitsabläufe und effizientere Bearbeitungszeiten. Die Zusammenarbeit zielt darauf ab, neue Standards in der kardiovaskulären Versorgung zu setzen, indem sie dem Personal von Carilion erstklassige Technologie und kontinuierliche klinische Fortbildung bietet. Diese Expansion bekräftigt Carilions Engagement für die Bereitstellung hochwertiger, patientenorientierter Versorgung in der Region.

Positive
  • Expansion of cardiovascular care capabilities with 11 new specialized Philips interventional suites
  • Implementation of advanced Philips technology, including AI-enabled ultrasound and image-guided therapy systems
  • Reduced X-ray dose and improved workflow efficiency
  • Ongoing clinical education for staff included in the service program
Negative
  • None.

Insights

Carilion Clinic's adoption of Philips' cardiovascular care ecosystem is a significant upgrade in their technological capabilities. The implementation of 11 specialized Philips interventional suites equipped with the Azurion Image-Guided Therapy System and other advanced tools represents a substantial investment in cutting-edge medical technology.

This move is likely to enhance Carilion's competitive position in the region by offering advanced cardiovascular care closer to patients' homes. The reduced X-ray dose and improved workflow efficiency could lead to better patient outcomes and potentially higher patient throughput, which may positively impact Carilion's financial performance.

For Philips, this deal strengthens its market position in the cardiovascular care segment and showcases the company's ability to provide integrated solutions. However, the financial impact on Philips may be , as this is a single-institution deal in a specific region.

Carilion Clinic's expansion with Philips technology demonstrates a strategic focus on cardiovascular care, a high-revenue service line for many hospitals. By centralizing these services in a new facility with state-of-the-art equipment, Carilion is positioning itself as the premier cardiovascular care provider in the region.

This move could lead to increased patient volume, particularly for complex cases that might otherwise be referred to more distant urban centers. The potential for improved outcomes and reduced procedure times could also enhance Carilion's quality metrics, which are increasingly tied to reimbursement rates in value-based care models.

However, the substantial investment in technology and infrastructure carries financial risks. Carilion will need to ensure high utilization rates and effective marketing to realize a return on this investment. The success of this initiative could serve as a model for other regional health systems looking to expand their specialty services.

August 20, 2024

  • Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes
  • New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home

Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a not-for-profit health care organization serving more than one million people in the States of Virginia and West Virginia, today announced Carilion will adopt the Philips cardiovascular care ecosystem of solutions at the future home of its Cardiovascular Institute at Crystal Spring Tower. Carilion’s new facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home while optimizing the clinical, operational and overall performance of the health system’s cardiovascular service line. This investment illustrates Carilion’s commitment to empowering its clinicians with innovative technology to provide quality care for its communities.

Carilion’s comprehensive hospital network, primary and specialty physician practices and other complementary services deliver high-quality, patient-centered care. The flagship hospital, Carilion Roanoke Memorial Hospital, totals 718 beds. The Carilion Clinic Cardiovascular Institute will relocate to this new facility and provide state-of-the art heart, lung and vascular services to the region. Services include inpatient nursing care, cardiovascular ORs, cardiac catheterization and electrophysiology labs.

Along with caring for the local community, Carilion Roanoke Memorial Hospital is the major referral center and only Level 1 Trauma Center for patients in the region who require specialized medical care. It also has the only hybrid operating rooms available in Southwest Virginia. Equipped with these new Philips solutions, the highly skilled medical staff will be able to continue handling complex cases or procedures that may not be available at surrounding healthcare facilities.

“At Carilion Clinic, we are committed to improving the health of the communities we serve. We know that collaboration is an essential component to realizing this vision,” said Marguerite Underwood, Vice President for the Carilion Clinic Cardiovascular Institute. “Working with Philips ensures that we will be able to set the standard in cardiovascular care, not only today, but well into the future.”

The new labs are the foundation of the integrated Philips ecosystem of solutions for cardiovascular care and include the Philips Azurion Image-Guided Therapy System, along with EPIQ CVx cardiology ultrasound system with ultrasound enabled AI capabilities, IntraSight with SyncVision for IVUS imaging and physiology and interventional tools. Together, the technology provides exceptional imaging with reduced X-ray dose [1], improved workflow and more efficient turnaround times [2], offering a high level of clinical confidence. A service program will reduce maintenance complexity, keeping systems up to date with the latest software. Furthermore, Carilion will be able to leverage ongoing clinical education for its staff.

“For many years, Carilion has been recognized for delivering exceptional cardiac care. Maintaining the highest standard of care means continuous growth and innovation, making healthcare delivery more efficient and effective,” said Jeff DiLullo, Chief Region Leader, Philips North America. “The Crystal Spring Tower expansion illustrates Carilion’s commitment to its staff and patients, giving clinicians access to world-class technology while providing a level of care not available anywhere else in the region.”

[1] In 37 individual comparative studies, Philips ClarityIQ was associated with reductions in patient radiation exposure. The results of the application of dose reduction techniques will vary depending on the clinical task, patient size, anatomical location and clinical practice. The interventional radiologist assisted by a physicist as necessary has to determine the appropriate settings for each specific clinical task.
[2] Results from study conducted at St. Antonius Hospital. Results verified by NAMSA, independent third-party expert on study design and analytics. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.

For more information:


Avi Dines
Philips North America
Tel: +1 781 690 3814
Email: avi.dines@philips.com

Joost Maltha
Philips Global External Relations
Tel: +31 6 10 55 8116
Email: joostm.maltha@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About Carilion Clinic’s Cardiovascular Institute (CVI)
As southwest Virginia’s cardiovascular care leader, our award-winning team combines continuous research and the latest technological advances with patient-centered care to ensure better surgical outcomes, fewer complications and faster recovery times.

With almost 800 members, the CVI team offers expert care across the cardiovascular spectrum, from medical, surgical, pre- and post-operative, rehab therapies, imaging and beyond. Moreover, our cardiac surgery intensive care unit and hybrid operating rooms allow for dedicated and focused care for cardiac patients. Our institute is recognized nationally for clinical excellence , including U.S. News & World Report honors and accreditations for our ventricular assist device program, chest pain center and catheterization lab. Acting as a valued clinical trial site, CVI patients receive cutting-edge care locally, offering access to innovative and minimally invasive procedures close to home. To learn more, visit CarilionClinic.org.

Attachments


FAQ

What new technology is Carilion Clinic adopting from Philips (PHG) for its Cardiovascular Institute?

Carilion Clinic is adopting Philips' cardiovascular care ecosystem, including the Azurion Image-Guided Therapy System, EPIQ CVx cardiology ultrasound with AI capabilities, and IntraSight with SyncVision for imaging and physiology.

How many Philips interventional suites will be installed at Carilion Clinic's new facility?

Carilion Clinic's new Cardiovascular Institute at Crystal Spring Tower will have 11 specialized Philips interventional suites.

What are the benefits of the new Philips (PHG) technology for Carilion Clinic's cardiovascular care?

The new Philips technology offers reduced X-ray dose, improved workflow, more efficient turnaround times, and a higher level of clinical confidence. It also includes ongoing clinical education for staff and a service program to keep systems up to date.

Where is Carilion Clinic's new Cardiovascular Institute located?

Carilion Clinic's new Cardiovascular Institute will be located at Crystal Spring Tower in Virginia, US.

KONINKLIJKE PHILIPS N.V.

NYSE:PHG

PHG Rankings

PHG Latest News

PHG Stock Data

23.31B
931.99M
6.87%
0.25%
Medical Devices
Healthcare
Link
United States of America
Amsterdam